Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

ESMO Open, 2025
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors

Naing A., McKean M., Rosen L. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Gut, 2025
Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration

Hardy M., Russell A., Henneken L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

European Journal of Nutrition, 2025
Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort

Xia L., Girerd N., Lamiral Z. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

Scientific Reports, 2025
Biomarkers of inflammation in sweat after myocardial infarction

Björkenheim A., Sunnefeldt E., Finke K. et al.

Olink Target 96CVDTechnical EvaluationPlasmaSweat

Aging Cell, 2025
Healthy Aging Metabolomic and Proteomic Signatures Across Multiple Physiological Compartments

Moaddel R., Candia J., Ubaida‐Mohien C. et al.

Olink Explore 3072/384AgingPathophysiologyPlasmaUrine

Translational Psychiatry, 2025
Predicting antipsychotic responsiveness using a machine learning classifier trained on plasma levels of inflammatory markers in schizophrenia

Yee J., Phua S., See Y. et al.

Olink Target 96NeurologyPatient StratificationPlasma

The Journal of Clinical Endocrinology & Metabolism, 2025
Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes

Gurung R., Zheng H., Tan J. et al.

Olink Explore 3072/384Metabolic DiseasesNephrologyPathophysiologyPlasma

Nature, 2025
Genetic architecture in Greenland is shaped by demography, structure and selection

Stæger F., Andersen M., Li Z. et al.

Olink Target 96Wider Proteomics StudiesPathophysiologyPlasma

Cytokine, 2025
A pilot investigation on inflammatory markers and theta burst stimulation protocol interaction along a three-month recovery course following an isolated upper limb fracture

Robitaille B., Herrero Babiloni A., Jodoin M. et al.

Olink Explore 3072/384Other Diseases & SyndromesPathophysiologySerum

European Journal of Nutrition, 2025
Plant-based dietary patterns, genetic risk, proteome, and lung cancer risk: a large prospective cohort study

Zhu W., Shi Z., Yan X. et al.

Olink Explore 3072/384OncologyNutritional SciencePathophysiologyPlasma

Children, 2025
Novel Inflammatory Biomarkers for Autism Spectrum Disorder Detected by Plasma Olink Proteomics

Lv T., Wang M., Kui L. et al.

Olink Target 96NeurologyPatient StratificationPlasma

eBioMedicine, 2025
Linking obesity-associated genotype to child language development: the role of early-life neurology-related proteomics and brain myelination

Huang J., Che J., Kee M. et al.

Olink Target 96Metabolic DiseasesNeurologyPathophysiologyPlasma

PROTEOMICS, 2025
Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 Cohort

Taleb S., Stephan N., Chennakkandathil S. et al.

Olink Target 96Wider Proteomics StudiesInfectious DiseasesTechnology EvaluationCross-platform ValidationPlasma

Pediatric Research, 2025
Gut microbiota, inflammatory cytokines, and Kawasaki disease: a Mendelian randomization study and mediation analysis

Wang J., Dou H., Liang Q.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Nature Genetics, 2025
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups

Hoffmann T., Graff R., Madduri R. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Frontiers in Endocrinology, 2025
Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

Wang C., Feng Y., Chen Y. et al.

Olink Target 96ObstetricsPatient StratificationSerumFollicular Fluid

Brain Communications, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

van Eijk R., Steyn F., Janse van Mantgem M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Arthritis Research & Therapy, 2025
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype

Xu X., Qiu T., Sun K. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

International Journal of Chronic Obstructive Pulmonary Disease, 2025
The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD

Yan K., Wang Y., Xin P.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

Movement Disorders, 2025
Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [11C]PBR28 PET

Wallin J., Forsberg A., Svenningsson P.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

3478 publications